மருந்துகள் நாஸ்டாக் News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from மருந்துகள் நாஸ்டாக். Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In மருந்துகள் நாஸ்டாக் Today - Breaking & Trending Today

ASLAN PHARMACEUTICALS TO PARTICIPATE IN THE 2021 CANTOR VIRTUAL GLOBAL HEALTHCARE CONFERENCE

ASLAN PHARMACEUTICALS TO PARTICIPATE IN THE 2021 CANTOR VIRTUAL GLOBAL HEALTHCARE CONFERENCE
pharmiweb.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from pharmiweb.com Daily Mail and Mail on Sunday newspapers.

United States , Menlo Park , Carl Firth , Pharmaceuticals Nasdaq , Virtual Global Healthcare Conference , ஒன்றுபட்டது மாநிலங்களில் , மென்லோ பூங்கா , கார்ல் ஃபர்த் , மருந்துகள் நாஸ்டாக் , மெய்நிகர் உலகளாவிய சுகாதாரம் மாநாடு ,

ASLAN Pharmaceuticals to Present Data on ASLAN004 at Society for Investigative Dermatology

Press release content from Globe Newswire. The AP news staff was not involved in its creation.
ASLAN Pharmaceuticals to Present Data on ASLAN004 at Society for Investigative Dermatology
ASLAN PHARMACEUTICALS LIMITEDMay 5, 2021 GMT
- ASLAN will give a poster presentation of new data from its Single Ascending Dose (SAD) study of ASLAN004, during the virtual event on 6 May, 2021
SINGAPORE, May 05, 2021 (GLOBE NEWSWIRE) ASLAN Pharmaceuticals (NASDAQ: ASLN), a clinical-stage immunology focused biopharmaceutical company developing innovative treatments to transform the lives of patients, today announced that an abstract on ASLAN004 has been accepted for poster presentation at the upcoming 2021 Society for Investigative Dermatology (SID) virtual meeting between 3-8 May, 2021. The data is available to view during the Pharmacology and Drug Development segment on 6 May, 2.30pm to 4pm EST, and will be published in the fall edition of the Journal of Investigative Dermatolog ....

Singapore General , Hartina Hajireen , Robert Uhl , Emma Thompson , Commission File No , Exchange Commission On , Company Us Securities , Society For Investigative Dermatology , Pharmaceuticals Nasdaq , Drug Development , Exchange Commission , Company Annual Report On Form , Spurwing Communications , Clinical Trials Research Unit , Single Ascending Dose , Investigative Dermatology , Clinical Trials , Research Unit , Changi General Hospital , Multiple Ascending Dose , Commission File , Annual Report , சிங்கப்பூர் ஜநரல் , ராபர்ட் அல் , எம்மா தாம்சன் , தரகு கோப்பு இல்லை ,

ASLAN Pharmaceuticals Reports Fourth Quarter and Full Year 2020 Financial Results and Provides ...

Press release content from Globe Newswire. The AP news staff was not involved in its creation.
ASLAN Pharmaceuticals Reports Fourth Quarter and Full Year 2020 Financial Results and Provides .
ASLAN PHARMACEUTICALS LIMITEDApril 22, 2021 GMT
SINGAPORE, April 22, 2021 (GLOBE NEWSWIRE) ASLAN Pharmaceuticals (Nasdaq:ASLN), a clinical-stage immunology focused biopharmaceutical company developing innovative treatments to transform the lives of patients, today announced financial results for the fourth quarter and full year ended December 31, 2020 and provided an update on its clinical development activities.
Dr Carl Firth, Chief Executive Officer, ASLAN Pharmaceuticals, said:
“ASLAN made significant progress in the fourth quarter of 2020 and that momentum has carried over into 2021. After completing recruitment of the third cohort in our multiple ascending dose trial for ASLAN004 in the fourth quarter, we announced positive interim data supportive of its potenti ....

United Kingdom , Neil Graham , Robert Uhl , Carl Firth , Emma Thompson , Kathleenm Metters , Commission File No , Head Of Worldwide Basic Research , Regeneron Pharmaceuticals Inc , Preclinical Sciences , Exchange Commission On , Company Us Securities , Merck Co , Pharmaceuticals Nasdaq , University Of Liverpool , Exchange Commission , Stockholders Of The Company , Company Annual Report On Form , Spurwing Communications , Chief Executive Officer , Vitro Journal , Depositary Shares , Vivo Capital , Surveyor Capital , Regeneron Pharmaceuticals , External Discovery ,

ASLAN Pharmaceuticals Announces Pricing of Public Offering of American Depositary Shares

ASLAN Pharmaceuticals Announces Pricing of Public Offering of American Depositary Shares
globenewswire.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from globenewswire.com Daily Mail and Mail on Sunday newspapers.

New York , United States , Robert Uhl , Emma Thompson , Exchange Commission , Prospectus Department , Hc Wainwright Co , Equity Syndicate Prospectus Department , Spurwing Communications , Piper Sandler Co , Pharmaceuticals Nasdaq , Depositary Shares , Piper Sandler , Private Securities Litigation Reform Act , புதியது யார்க் , ஒன்றுபட்டது மாநிலங்களில் , ராபர்ட் அல் , எம்மா தாம்சன் , பரிமாற்றம் தரகு , ப்ரோஸ்பெக்டஸ் துறை , பங்கு கூட்டமைப்பு ப்ரோஸ்பெக்டஸ் துறை , பைபர் சாண்ட்லர் இணை , மருந்துகள் நாஸ்டாக் , பைபர் சாண்ட்லர் , ப்ரைவேட் பத்திரங்கள் வழக்கு சீர்திருத்தம் நாடகம் ,

ASLAN Pharmaceuticals Appoints Dr Neil Graham as Independent Director

ASLAN Pharmaceuticals Appoints Dr Neil Graham as Independent Director
apnews.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from apnews.com Daily Mail and Mail on Sunday newspapers.

T Ai Pei , Jun Wu , Neil Graham , Robert Uhl , Andrew Howden , Kelvin Sun , Emma Thompson , Regeneron Pharmaceuticals Inc , Pharmaxis Ltd , Pharmaceuticals Nasdaq , Tiziana Life Sciences , Strategic Program Direction , Spurwing Communications , Taipei Exchange , Global Strategic Program , Chief Medical Officer , Regeneron Pharmaceuticals , Alnair Investment , Nasdaq Global Market , டி ஐ பேய் , ஜூன் வு , நீல் கிரஹாம் , ராபர்ட் அல் , எம்மா தாம்சன் , மருந்துகள் நாஸ்டாக் , மூலோபாய ப்ரோக்ர்யாம் திசையில் ,